Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Gross PP&E Adjustments (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Other Gross PP&E Adjustments over the past 14 years, most recently at $186.4 million for Q2 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $186.4 million for Q2 2025, down 5.4% from a year ago — trailing twelve months through May 2025 was $186.4 million (down 5.4% YoY), and the annual figure for FY2025 was $186.4 million, down 5.4%.
  • Other Gross PP&E Adjustments for Q2 2025 was $186.4 million at Lifecore Biomedical, Inc. \De\, up from $181.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for LFCR hit a ceiling of $202.6 million in Q4 2024 and a floor of -$15.4 million in Q1 2021.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$3.3 million (2023), compared with a mean of $76.6 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 50.11% in 2021 and later soared 7330.6% in 2025.
  • Lifecore Biomedical, Inc. \De\'s Other Gross PP&E Adjustments stood at -$7.5 million in 2021, then increased by 29.87% to -$5.3 million in 2022, then increased by 23.14% to -$4.0 million in 2023, then soared by 5120.89% to $202.6 million in 2024, then decreased by 8.01% to $186.4 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $186.4 million (Q2 2025), $181.5 million (Q1 2025), and $202.6 million (Q4 2024) per Business Quant data.